Lars Müller has been an entrepreneur since the age of 15 and is currently one of the youngest CEOs of a publicly traded cannabis company. With SynBiotic SE, he is building a European platform to drive the research and development of new cannabinoid and terpene-based solutions to major societal problems such as pain, sleep and anxiety.
